PASG
Ticker
Passage Bio, Inc.
PASG · Healthcare · Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseasesPassage Bio, Inc. (PASG), in the Healthcare sector, has 1 disclosed filing on Paydirt over the trailing twelve months from 1 corporate insider: 1 purchase and 0 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Jun 25 and filed Jun 29. The most active filer was Lynx1 Capital Management LP with 5 filings.
Add to watchlistFilings, ttm
1
1 buy · 0 sells
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$206K
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Jun 25
Filed Jun 29
ADViAverage daily dollar volume
$394K
market data
Share price · 12M
$4.63 (-38.6%)
Adjusted for splits and dividends.
Volume by month
Buys $1.5M
Sells $138K
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
LL
Lynx1 Capital Management LP
10% owner
5 filings
OL
OrbiMed Capital GP VII LLC
10% owner
1 filing
Recent filings
Lynx1 Capital Management LPPURCHASE
10% owner
$206K50,055 sh × $4.12
Exec Jun 25
Filed Jun 29 · 4:30 PM ET Lynx1 Capital Management LPPURCHASE 10% owner $138K
19,783 sh × $6.99
Exec Sep 12 2025
Filed Sep 15 2025 · 8:05 PM ET Lynx1 Capital Management LPPURCHASE 10% owner $662K
115,725 sh across 2 lots
Exec Jul 23 2025
Filed Jul 24 2025 · 6:12 PM ET Lynx1 Capital Management LPPURCHASE 10% owner $243K
373,645 sh × $0.65
Exec Dec 27 2024
Filed Dec 31 2024 · 5:30 PM ET OrbiMed Capital GP VII LLCSALE 10% owner $138K
230,321 sh × $0.60
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET † Lynx1 Capital Management LPPURCHASE 10% owner $264K
427,053 sh across 2 lots
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET